Medical/Pharmaceuticals
Antengene Announces the Acceptance of ATG-010 (Selinexor) NDA by the NMPA for the Treatment of rrMM
SHANGHAI and HONG KONG, Jan. 28, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in class therapeutics in hematology and oncol...
2021-01-28 08:00
3806
Antengene Announces the Acceptance of ATG-010 (Selinexor) NDA by the NMPA for the Treatment of rrMM
SHANGHAI and HONG KONG, Jan. 28, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in class therapeutics in hematology and oncol...
2021-01-28 08:00
5276
Transnetyx, One Codex Build Strategic Partnership to Provide a Complete Microbiome Analysis Service for Both Mice and Humans
MEMPHIS, Tenn., Jan. 27, 2021 /PRNewswire/ -- Transnetyx, Inc. announced today its collaboration with One Codex on an end-to-end microbiome sequencing and analysis service. This offering will be driven by Transnetyx's wide-reaching global footprint in the model organism community and One Codex's ...
2021-01-28 03:29
1518
Valcare Medical Announces First-in-Human Transseptal Implant of the AMEND™ Annuloplasty Ring for Mitral Valve Repair
HERZLIYA, Israel, Jan. 28, 2021 /PRNewswire/ -- Valcare Medical Ltd. developer of transcatheter mitral and tricuspid valve repair and replacement solutions, announces that it has successfully completed its first-in-human transseptal delivery of the AMEND™ annuloplasty ring. The transseptal AMEND ...
2021-01-28 02:04
3987
Neurophth Therapeutics Further Expands Ocular Gene Therapy Expertise with Appointment of Qiutang Li, Ph.D., as Chief Scientific Officer
WUHAN, China and NEWARK, Del., Jan. 27, 2021 /PRNewswire/ -- Wuhan Neurophth Biotechnology Ltd., a fully-integrated genetic medicines company developing AAV-delivered gene therapies for the treatment of ocular diseases, today announced the appointment of Qiutang Li, Ph.D., as Chief Scientific Off...
2021-01-27 21:00
1828
Ajinomoto Bio-Pharma Services and Humanigen Expand Manufacturing Agreement to Support Fill Finish for Investigational COVID-19 Therapeutic, Lenzilumab, Nearing Completion of Phase 3 Study
SAN DIEGO and BURLINGAME, California, Jan. 27, 2021 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, and Humanigen, Inc. (NASDAQ: HGEN) ("Humanigen"), a clinical-stage biopharmaceutical compa...
2021-01-27 20:00
5050
Singapore-based Osteopore International Collaborates With Maastricht University Medical Centre To Develop Implant Solution That Prevents Leg Amputations
* Osteopore and Maastricht University Medical Centre has developed a first-of-its-kind, bioresorbable bone implant solution that prevents leg amputations in patients with severe lower leg fractures * Osteopore and National Additive Manufacturing Innovation Cluster have formed a partnership to...
2021-01-27 17:57
2142
Medeon Announces Positive Clinical Results for XFLO Minimally Invasive BPH Treatment Device
TAIPEI, Jan. 27, 2021 /PRNewswire/ -- Medeon Biodesign, Inc. (TPEx: 6499), a Taiwan publicly traded medical device company, is pleased to announce positive interim results of the EXPANDER-1 Clinical Study for its flagship product the XFLO™ Expander System, an innovative, minimally invasive Benign...
2021-01-27 17:41
2442
South Korean Medical AI Provider and PACS Leader Enters Indonesian Market, to Help COVID-19 Screening and Diagnosis
SEOUL, South Korea, Jan. 27, 2021 /PRNewswire/ -- Lunit, a South Korean medical
AI software company, announced a partnership with a leading PACS provider
INFINITT Healthcare to accelerate its global expansion.
2021-01-27 15:37
2485
Casio to Release DERMOCAMERA™, Allowing Dermatologists to Capture Close-up and Ordinary Shots of Affected Areas Using a Single Device
TOKYO, Jan. 27, 2021 /PRNewswire/ -- Casio Computer Co., Ltd. announced today the upcoming release of the DZ-D100 DERMOCAMERA that allows close-up shots with the lens directly touching the skin as well as ordinary shots, all using a single camera. The new product was created based on collaborativ...
2021-01-27 12:21
2879
Sihuan Pharmaceutical (0460.HK): Xuanzhu Biopharm acquires Combio Pharmaceutical, the large-molecule integrated development platform helps drive innovation
HONG KONG, Jan. 27, 2021 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. (the "Company" or "Sihuan Pharmaceutical", together with its subsidiaries, collectively referred to as the "Group"; Hong Kong Stock Exchange Stock Code: 0460) is pleased to announce its innovation Xuanzhu Biopharma...
2021-01-27 11:21
7951
Kingston x CSD Reveals APAC Top 10 heartwarming face mask designs
* Over 3,100 entries received across all APAC regions for Kingston x CSD APAC Mask Design Competition as artists induce positivity through mask designs, share compelling life stories and reflections on 2020 * Vote online now for the favourite finalist and decide who the winner will be TAIPEI, ...
2021-01-27 10:00
3125
Samsung Biologics, National OncoVenture, and Eutilex Obtain IND Approval from FDA
INCHEON, South Korea, Jan. 26, 2021 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS) announced another successful Investigational New Drug (IND) clearance from the FDA for its client to begin clinical trials on a cancer immunotherapy, furthering the company's track record as a premiere CDO serv...
2021-01-27 08:26
6503
Biocytogen Subsidiary Eucure Biopharma Reports First Patient Enrolled in anti-CTLA4 Phase I Trial in China
BOSTON and BEIJING, Jan. 26, 2021 /PRNewswire/ -- Eucure Biopharma, a subsidiary of Biocytogen, announced the first patient enrollment for a Phase I clinical trial inChina to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of its anti-CTLA4 monoclonal antibody (YH001)...
2021-01-26 23:45
1596
Precision Medicine Leader Caprion-HistoGeneX Rebrands as CellCarta
MONTREAL, Jan. 26, 2021 /PRNewswire/ -- Caprion-HistoGeneX, a leading global
provider of specialized precision medicine laboratory services to the
biopharmaceutical industry, is pleased to announce its new corporate name,
CellCarta, and brand identity.
2021-01-26 21:23
4942
Connect Biopharma Strengthens Leadership Team with Key Hire
New Chief Business Officer joins company as part of organizational growth strategy SAN DIEGO and TAICANG, SUZHOU, China, Jan. 26, 2021 /PRNewswire/ -- Connect Biopharma, a global clinical-stage biopharmaceutical company dedicated to improving the lives of patients with chronic inflammatory disea...
2021-01-26 21:00
1969
Mindray Transforms Spot Check Patient Monitoring with New VS Series Vital Signs Monitors
SHENZHEN, China, Jan. 26, 2021 /PRNewswire/ -- Mindray (SZSE: 300760), a global leader in the development of innovative healthcare technology, today launched its new VS 9 and VS 8 Vital Signs Monitors, which are now available inEurope, Australia and other selected regions. From inpatient admissio...
2021-01-26 19:29
7138
Maypharm Announces New Product METOX on Times Square in New York
SEOUL, South Korea and NEW YORK, Jan. 26, 2021 /PRNewswire/ -- Maypharm
announces new botulinum toxin, METOX onJanuary 26, 2021. METOX is an effective
solution for smoothing any kind of wrinkles from moderate to severe, caused by
daily active facial movements.
2021-01-26 17:00
1968
I-Mab and MorphoSys Announce First Patient Dosed in U.S. Phase 1 Study of TJ210/MOR210 in Patients with Advanced Cancer
SHANGHAI, China and PLANEGG/MUNICH, Germany, Jan. 25, 2021 /PRNewswire/ -- I-Mab (Nasdaq: IMAB), and MorphoSys (FSE: MOR; Prime Standard Segment, MDAX & TecDAX; NASDAQ: MOR) today announced that the first patient has been dosed in a phase 1 dose escalation study to evaluate the safety, tolerabili...
2021-01-26 05:05
3751
BioNTech and Fosun Pharma Receive Authorization for Emergency Use in Hong Kong for COVID-19 Vaccine
MAINZ, Germany and SHANGHAI, China, 25 Jan. 2021 /PRNewswire/ -- BioNTech SE (Nasdaq: BNTX, "BioNTech" or "the Company") andShanghai Fosun Pharmaceutical (Group) Co., Ltd. ("Fosun Pharma" or "Group"; Stock Code: 600196.SH, 02196.HK) today announced that according to the Food and Health Bureau of ...
2021-01-26 01:18
6423
Week's Top Stories
Most Reposted
Edufrienz 99: One of Asia's First Digital Platform Advancing Character Education for Future-Ready, Compassionate Children
[Picked up by 313 media titles]
2026-01-23 11:03
UOB prices AUD2 billion in five-year senior unsecured notes
[Picked up by 304 media titles]
2026-01-23 09:00AVPN's AI Opportunity Fund Expands Regional Efforts to Build AI Skilling Infrastructure for a Future-Ready Workforce Across Asia-Pacific
[Picked up by 302 media titles]
2026-01-21 12:39Government of Telangana and Blaize Sign MoU at Davos to Launch Telangana AI Innovation Hub and Advance Applied AI Initiatives
[Picked up by 297 media titles]
2026-01-22 15:16
Klook's study of 374,000 reviews finds that lesser-known cities create deeper emotional connection with travelers
[Picked up by 280 media titles]
2026-01-20 15:40
Most Read
GIGABYTE Strengthens NVIDIA® Partnership to Drive Innovation in AI-Powered Gaming and Creative Solutions
2026-01-17 00:00
7212
GAC Energy Releases 2025 EV Charging Ecosystem Report: Over 23,000 Self-Operated Charging Piles Across China
2026-01-17 10:59
5788
